European Annals of Otorhinolaryngology-Head and Neck Diseases最新文献

The art of persuasion.

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2024-12-12 DOI: 10.1016/j.anorl.2024.11.003

O Laccourreye

引用次数: 0

The International Francophone ENT Society (SIFORL): A dynamic and ambitious society.

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2024-12-11 DOI: 10.1016/j.anorl.2024.11.009

R P Adjoua, E Truy, E Babin, C A Righini

引用次数: 0

Sexual harassment of physicians by patients.

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2024-12-11 DOI: 10.1016/j.anorl.2024.11.001

O Laccourreye

引用次数: 0

First example of airway restoration using cryopreserved aortic allograft after total laryngectomy: CARE case report.

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2024-12-09 DOI: 10.1016/j.anorl.2024.11.007

C Debry, E Brenet, E Martinod, P Lavalle, A Dupret-Bories, P Schultz, L Fath

{"title":"First example of airway restoration using cryopreserved aortic allograft after total laryngectomy: CARE case report.","authors":"C Debry, E Brenet, E Martinod, P Lavalle, A Dupret-Bories, P Schultz, L Fath","doi":"10.1016/j.anorl.2024.11.007","DOIUrl":"https://doi.org/10.1016/j.anorl.2024.11.007","url":null,"abstract":"Case description: A 70 year-old woman presenting T4aN2cM0 laryngeal carcinoma first underwent total laryngectomy with airway reconstruction by cryopreserved aortic allograft. Six months after chemoradiotherapy, she underwent endoscopic surgery to create a neo-laryngopharynx.Results: At 13 months after primary surgery, day- and night-time breathing was effectively restored, with a little persistent salivary false passage, and a whispering but comprehensible voice after tracheostomy closure. Swallowing was possible for small amounts of soft food, thanks to sustained rehabilitation, although normal feeding was not achieved. The patient showed no episodes of pneumopathy. General health status was good, with no oncologic relapse.Discussion: This was the first case of laryngeal replacement by cryopreserved aortic allograft, showing progress in the decades-long aim of final tracheostomy closure. The ultimate objective is to achieve swallowing without false passage, by improving various aspects of surgical technique,without, so far as possible, making the procedures more complex by active airway protection systems.","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Stimulator of interferon genes-associated vasculopathy with onset in infancy (SAVI syndrome).

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2024-12-09 DOI: 10.1016/j.anorl.2024.11.008

M Saro-Buendía, M Mansilla-Polo, A García-Piñero, M Armengot-Carceller

引用次数: 0

Audiometric results of tympanoplasty with stapedectomy and synthetic total ossicular replacement prosthesis: A STROBE analysis.

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2024-12-06 DOI: 10.1016/j.anorl.2024.11.006

C Guigou, M Folia, B Reliquet, A Lalande, M Brisson, A Bozorg Grayeli

{"title":"Audiometric results of tympanoplasty with stapedectomy and synthetic total ossicular replacement prosthesis: A STROBE analysis.","authors":"C Guigou, M Folia, B Reliquet, A Lalande, M Brisson, A Bozorg Grayeli","doi":"10.1016/j.anorl.2024.11.006","DOIUrl":"https://doi.org/10.1016/j.anorl.2024.11.006","url":null,"abstract":"Aim: To evaluate the audiometric results of tympanoplasty with stapedectomy and insertion of a synthetic total ossicular replacement prosthesis (TORP).Material and methods: Retrospective observational study conducted on a cohort of 15 patients (16 ears) aged 10 to 58 years (mean: 36 years) with chronic otitis media (COM) and tympanosclerosis (n=9), stapediovestibular ankylosis (n=3), minor aplasia (n=3) or post-traumatic ossicular dislocation (n=1). Treatment consisted in tympanoplasty with stapedectomy and TORP placement by the same operator, between December 1, 2012 and January 30, 2023, in a French university hospital department, with follow-up ranging from 2 to 92 months (mean: 24 months). The primary endpoint was postoperative change in air conduction (AC) threshold and air-bone gap (ABG). Secondary endpoints comprised change in speech recognition threshold (SRT) and speech discrimination score (SDS) and analysis of complications. The STROBE editorial line was followed and the significance threshold was set at P<0.005.Results: There was significant improvement in AC threshold (-2 to 25dB, mean: 10dB; P=0.001), ABG (-8 to 26dB, mean: 10dB), SRT (2 to 30dB, mean: 13dB; P<0.0001) and SDS (P=0.001). No patients showed vestibular symptoms postoperatively.Conclusion: This study suggests that this technique is a possible and safe therapeutic option in selected cases of stapes footplate fixation associated with other ossicular anomalies.","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142792645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

External auditory canal chondroid syringoma with bone erosion: A CARE case report.

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2024-12-03 DOI: 10.1016/j.anorl.2024.11.004

J Connesson, C Beck, C Vincent, P Toulemonde

引用次数: 0

Environmental impact of pediatric ENT surgery: A STROBE analysis.

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2024-12-03 DOI: 10.1016/j.anorl.2024.11.005

M Martin, S Ayraud-Thevenot, X Dufour, J-P Lebreton, J Guihenneuc, F Carsuzaa

{"title":"Environmental impact of pediatric ENT surgery: A STROBE analysis.","authors":"M Martin, S Ayraud-Thevenot, X Dufour, J-P Lebreton, J Guihenneuc, F Carsuzaa","doi":"10.1016/j.anorl.2024.11.005","DOIUrl":"https://doi.org/10.1016/j.anorl.2024.11.005","url":null,"abstract":"Introduction: Increasing emissions of greenhouse gases contribute to climate change. The healthcare sector, and particularly the operating room, is a significant emitter of greenhouse gases. In head-and-neck surgery, pediatric procedures are very common, but few studies have assessed their ecological impact. Our objective was to quantify the carbon footprint of common pediatric head-and-neck surgeries (tonsillectomy, adenoidectomy, and transtympanic tube placement).Methods: An eco-epidemiological study was conducted in December 2022 in a tertiary hospital center. The carbon footprint of 10 pediatric head-and-neck surgeries (tonsillectomies, adenoidectomies, transtympanic tube placements) was calculated, as the sum of carbon dioxide (CO2eq) emissions generated by patient and medical staff transport, waste production, energy consumption in operating rooms, manufacturing and transport of disposable and reusable medical devices (MDs), medication production, and sterilization of reusable MDs.Results: The carbon footprint of 1 pediatric head-and-neck surgery was 57.86kgCO2eq. Disposable MDs were the most polluting item with 30.82kgCO2eq (53.3%). Patient transport accounted for 27.4%, medication for 12.6% and reusable MDs for 2.9%.Conclusions: Pediatric head-and-neck surgeries generate a significant quantity of CO2, mostly due to the production and delivery of disposable MDs. These observations could serve as a starting point for ecological actions consistent with an environmentally sustainable and climate-resilient health system.","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142781576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Scientific and skeptical medical writing.

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2024-12-03 DOI: 10.1016/j.anorl.2024.11.002

F Simon

引用次数: 0

Treatment of epistaxis in Osler-Weber-Rendu disease by bevacizumab nasal spray. The EROSB study: Determining the effective dose. 贝伐珠单抗鼻喷雾剂治疗奥斯勒-韦伯-伦杜病鼻衄。EROSB研究：确定有效剂量。

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2024-11-06 DOI: 10.1016/j.anorl.2024.10.006

L Vincent, L Robard, C Creveuil, E Babin, M Perreard, M Humbert

{"title":"Treatment of epistaxis in Osler-Weber-Rendu disease by bevacizumab nasal spray. The EROSB study: Determining the effective dose.","authors":"L Vincent, L Robard, C Creveuil, E Babin, M Perreard, M Humbert","doi":"10.1016/j.anorl.2024.10.006","DOIUrl":"https://doi.org/10.1016/j.anorl.2024.10.006","url":null,"abstract":"Treatment of nosebleeds in Osler-Weber-Rendu disease (OWRD) is a therapeutic challenge. Intranasal anti-angiogenic sprays are a promising solution, requiring scientific validation, leading us to conduct the present study.Objective: The main objective was to determine the minimum effective dose of bevacizumab by intranasal spray to treat epistaxis in OWRD: i.e., the dose resulting in≥50% reduction in the number of nosebleeds at 1 month of treatment compared to the month prior to inclusion for 60% of patients. The secondary objectives were to assess treatment efficacy at 3 and 6 months and progression in the number and impact of nosebleeds, and to document pharmacokinetics.Materials and methods: The study, named EROSB (treatment of epistaxis in patients with OWRD using a bevacizumab intranasal spray), under the French Hospitals Clinical Research Program (PHRC-I 2013), was selected by the Inter-regional Clinical Research and Innovation Group (GIRCI). It was a phase I/II prospective single-blind study based on 10 cohorts of 3 patients each, using the Continual Reassessment Method (CRM) to determine the minimum effective dose of bevacizumab.Results: Due to difficulties in recruiting enough patients, the study was stopped after inclusion of 15 subjects. The CRM method identified 64mg as the minimum effective dose. However, this result is not interpretable due to the small number of subjects.Conclusion: The EROSB study did not succeed in identifying a minimum effective dose of bevacizumab, administered as intranasal spray that could reduce the number of nosebleeds compared to the month prior to inclusion. However, the initial results indicated almost no systemic passage of the substance.","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0